SARS-CoV-2 S1 (RBD) Lambda C.37 (Peru), GFP/His-Tag citations

SARS-CoV-2 S1 (RBD) Lambda C.37 (Peru), GFP/His-Tag citationsRecombinant protein of the receptor binding domain (RBD), Mutant (L452Q F490S) of SARS CoV 2 (COVID 2019) Spike S1 from Wuhan pneumonia virus with C terminal His GFP Tag. The mutations L452Q F490S are characteristic for the SARS CoV 2 virus variant C. 37 emerged in South America (Peru) in late 2020. C. 37 is classified as Variant of Interest (VOI) and also known as Lambda variant. The mutations are affecting the receptor binding domain (RBD) of the

Grey lines correspond to a global fit of the data using a 1:1 binding model

GFP/His-Tag (P2020-041)

RefSeq Links: UniProt: P01137

150 mM NaCl

including macrophages

precise modulation of TGF-β1 signaling holds therapeutic promise in various diseases

This mutation seems to have no significant impact on the clinical spectrum of disease and not more transmissible than Delta

Cystatin C is a small

Omicron variant BA

also known as cluster of differentiation 80 (CD80)

Test Cleavage

Brazilian lineage